Literature DB >> 15861216

Molecular assessment of allelic loss in Warthin tumors.

Muammar Arida1, E Leon Barnes, Jennifer L Hunt.   

Abstract

Warthin's tumors are benign lesions of the head and neck that have a characteristic morphologic appearance. The etiology of Warthin's tumors is controversial and whether they are true neoplasms or developmental malformations continues to be debated. In this study, we examined 12 Warthin tumors with a molecular and immunohistochemical approach. Immunostains for p53 and p16ink were performed. The epithelial and lymphoid components of each lesion were microdissected and PCR was performed for 13 microsatellite markers at or near common tumor suppressor genes. The results were analyzed semiquantitatively using capillary electrophoresis. Frequency of allelic loss was calculated. The epithelial component of all tumors was negative for p53 and p16ink. By molecular genotyping there was only one case that had one locus with allelic imbalance, while the remainder had no evidence of clonal allelic loss. The immunohistochemical and molecular results in this study lend support to the hypothesis that Warthin tumors are non-neoplastic, as there was no evidence of aberrant staining for tumor suppressor gene protein products and no evidence of consistent clonal allelic losses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861216     DOI: 10.1038/modpathol.3800379

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

1.  Bilateral and multifocal Warthin's tumor of parotid gland: two case reports and review of literature.

Authors:  G Nicolai; E Ventucci; P Antonucci; V Costantino; G Brunelli; G Mariani; A Saltarel; B Lorè; L Calabrese
Journal:  Oral Implantol (Rome)       Date:  2014-12-27

2.  Warthin tumor within the superficial lobe of the parotid gland: a suggested criterion for diagnosis.

Authors:  Doron Sagiv; Robert L Witt; Eran Glikson; Jobran Mansour; Bruria Shalmon; Arkadi Yakirevitch; Michael Wolf; Eran E Alon; Guy Slonimsky; Yoav P Talmi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-24       Impact factor: 2.503

3.  The role of fine-needle aspiration biopsy (FNAB) in Warthin tumour diagnosis and management.

Authors:  Alzbeta Jechova; Martin Kuchar; Stepan Novak; Vladimir Koucky; Lucie Dostalova; Michal Zabrodsky; David Kalfert; Jan Plzak
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-18       Impact factor: 2.503

4.  Increased incidence of Warthin tumours of the parotid gland: a 42-year evaluation.

Authors:  Achim M Franzen; Christiane Kaup Franzen; Thomas Guenzel; Anja Lieder
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-18       Impact factor: 2.503

5.  Unilateral Warthin's tumour in a patient of Afro-Caribbean descent.

Authors:  Ki Quintyne; F Wallis; V Healy; N Shine
Journal:  BMJ Case Rep       Date:  2014-06-02

6.  Multifocal multi-site Warthin tumour.

Authors:  Jennifer M Hilton; John S Phillips; Henrik B Hellquist; Don J Premachandra
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-27       Impact factor: 2.503

7.  Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.

Authors:  Jochen Winter; Annette Pantelis; Dominik Kraus; Jan Reckenbeil; Rudolf Reich; Soeren Jepsen; Hans-Peter Fischer; Jean-Pierre Allam; Natalija Novak; Matthias Wenghoefer
Journal:  BMC Cancer       Date:  2012-10-11       Impact factor: 4.430

8.  Immunohistochemical localization of mdm-2, p27Kip1 and bcl-2 in Warthin's tumor of the parotid gland.

Authors:  Ehab S Abd-Elhamid; Marwa M Elshafei
Journal:  Diagn Pathol       Date:  2009-05-16       Impact factor: 2.644

9.  Adenolymphoma: A probing entity: Case report and review.

Authors:  Anand Pratap Singh; Ankita Tandon; Aman Chowdhary; Sheetal Mujoo
Journal:  J Nat Sci Biol Med       Date:  2013-07

10.  Warthin's tumour of the parotid gland: our experience.

Authors:  T C Chulam; A L Noronha Francisco; J Goncalves Filho; C A Pinto Alves; L P Kowalski
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-12       Impact factor: 2.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.